Technical Articles

efficacy evaluation model

KRAS Drug Screening and Bioanalytical Technology Platform—From Recombinant Proteins to Cellular Functional Assays

2026-06-10

The development of KRAS-targeted drugs relies on a variety of biochemical and cellular analytical platforms. From the production and quality control of target proteins, to the measurement of compound binding affinity with KRAS, and the validation of signaling pathway inhibition in cells, a standardized analytical process is an essential infrastructure for new drug discovery.

View details

Cancer
Recombinant KRAS protein
nucleotide exchange assay
TR-FRET
RAS-RAF binding assay
cell proliferation assay
efficacy evaluation model

Total 1

Go to